 Richard Benninger
Concepts (272)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin-Secreting Cells | 28 | 2026 | 388 | 8.880 |
Why?
| | Islets of Langerhans | 34 | 2026 | 833 | 8.460 |
Why?
| | Gap Junctions | 18 | 2026 | 67 | 6.420 |
Why?
| | Connexins | 12 | 2026 | 56 | 3.380 |
Why?
| | Insulin | 27 | 2026 | 2507 | 2.960 |
Why?
| | Calcium | 17 | 2026 | 1183 | 2.910 |
Why?
| | Calcium Signaling | 13 | 2026 | 251 | 2.710 |
Why?
| | Contrast Media | 6 | 2026 | 488 | 2.430 |
Why?
| | Cell Communication | 6 | 2021 | 324 | 1.650 |
Why?
| | Pancreas | 6 | 2022 | 341 | 1.420 |
Why?
| | Diabetes Mellitus, Type 2 | 7 | 2023 | 2583 | 1.380 |
Why?
| | Diabetes Mellitus, Type 1 | 9 | 2026 | 3890 | 1.340 |
Why?
| | Ultrasonography | 7 | 2026 | 770 | 1.210 |
Why?
| | Mice | 40 | 2026 | 18339 | 1.180 |
Why?
| | Diabetes Mellitus | 6 | 2023 | 1098 | 1.180 |
Why?
| | Glucose | 12 | 2026 | 1047 | 1.160 |
Why?
| | Animals | 52 | 2026 | 38058 | 1.100 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2025 | 780 | 1.000 |
Why?
| | Glucokinase | 2 | 2025 | 15 | 0.840 |
Why?
| | Drug Delivery Systems | 1 | 2026 | 380 | 0.740 |
Why?
| | Pericytes | 1 | 2022 | 36 | 0.720 |
Why?
| | Cell Membrane | 3 | 2015 | 706 | 0.720 |
Why?
| | Cytokines | 5 | 2026 | 2061 | 0.720 |
Why?
| | Microscopy, Fluorescence | 4 | 2008 | 416 | 0.720 |
Why?
| | Mice, Inbred NOD | 6 | 2026 | 610 | 0.700 |
Why?
| | Mice, Knockout | 12 | 2026 | 3121 | 0.700 |
Why?
| | Protein Kinase C-delta | 2 | 2024 | 46 | 0.670 |
Why?
| | Software | 2 | 2025 | 690 | 0.660 |
Why?
| | Vagus Nerve | 1 | 2021 | 91 | 0.640 |
Why?
| | Peptides | 1 | 2026 | 995 | 0.630 |
Why?
| | Prediabetic State | 2 | 2020 | 245 | 0.610 |
Why?
| | Models, Biological | 7 | 2024 | 1821 | 0.600 |
Why?
| | Microbubbles | 4 | 2026 | 53 | 0.600 |
Why?
| | Algorithms | 3 | 2025 | 1837 | 0.580 |
Why?
| | Caloric Restriction | 1 | 2020 | 127 | 0.580 |
Why?
| | Photons | 3 | 2008 | 76 | 0.570 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2018 | 64 | 0.560 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2018 | 198 | 0.510 |
Why?
| | KATP Channels | 2 | 2014 | 17 | 0.500 |
Why?
| | Mice, Inbred C57BL | 11 | 2026 | 5992 | 0.500 |
Why?
| | Optics and Photonics | 3 | 2013 | 41 | 0.470 |
Why?
| | Fluorescence Polarization | 1 | 2015 | 24 | 0.440 |
Why?
| | Microscopy, Confocal | 3 | 2015 | 321 | 0.430 |
Why?
| | Fluorescence Recovery After Photobleaching | 1 | 2014 | 20 | 0.430 |
Why?
| | Systems Biology | 1 | 2014 | 72 | 0.410 |
Why?
| | Optogenetics | 3 | 2021 | 109 | 0.400 |
Why?
| | Glucagon | 2 | 2026 | 112 | 0.380 |
Why?
| | Fluorescent Dyes | 3 | 2015 | 329 | 0.370 |
Why?
| | Microscopy | 2 | 2013 | 156 | 0.360 |
Why?
| | Blood Glucose | 8 | 2026 | 2327 | 0.360 |
Why?
| | Cation Transport Proteins | 3 | 2022 | 118 | 0.360 |
Why?
| | Mice, SCID | 3 | 2022 | 369 | 0.340 |
Why?
| | Cell Differentiation | 3 | 2018 | 2050 | 0.340 |
Why?
| | Cell Proliferation | 2 | 2018 | 2496 | 0.340 |
Why?
| | Homeodomain Proteins | 3 | 2026 | 523 | 0.330 |
Why?
| | Nitric Oxide | 1 | 2015 | 897 | 0.330 |
Why?
| | Imaging, Three-Dimensional | 4 | 2025 | 583 | 0.330 |
Why?
| | Mice, Transgenic | 6 | 2017 | 2182 | 0.320 |
Why?
| | Hyperglycemia | 1 | 2014 | 375 | 0.310 |
Why?
| | Fluorescence | 5 | 2015 | 161 | 0.310 |
Why?
| | Immunological Synapses | 1 | 2009 | 16 | 0.290 |
Why?
| | Hypoglycemic Agents | 1 | 2018 | 1387 | 0.290 |
Why?
| | Humans | 29 | 2024 | 144759 | 0.280 |
Why?
| | Regional Blood Flow | 2 | 2022 | 514 | 0.270 |
Why?
| | Lasers | 1 | 2008 | 132 | 0.270 |
Why?
| | Cells | 1 | 2008 | 25 | 0.270 |
Why?
| | Microscopy, Fluorescence, Multiphoton | 1 | 2008 | 69 | 0.260 |
Why?
| | Membrane Potentials | 3 | 2025 | 280 | 0.260 |
Why?
| | Microfluidics | 1 | 2007 | 62 | 0.240 |
Why?
| | Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2026 | 31 | 0.240 |
Why?
| | Aging | 1 | 2017 | 1966 | 0.240 |
Why?
| | Zinc | 3 | 2019 | 295 | 0.230 |
Why?
| | Homeostasis | 3 | 2022 | 640 | 0.230 |
Why?
| | Killer Cells, Natural | 1 | 2009 | 467 | 0.230 |
Why?
| | Coloring Agents | 2 | 2021 | 93 | 0.220 |
Why?
| | Nanotechnology | 1 | 2006 | 126 | 0.220 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 2 | 2018 | 125 | 0.220 |
Why?
| | Bone Morphogenetic Protein 4 | 1 | 2024 | 43 | 0.220 |
Why?
| | Zinc Transporter 8 | 3 | 2022 | 70 | 0.210 |
Why?
| | Palate | 1 | 2024 | 39 | 0.210 |
Why?
| | Gastrectomy | 1 | 2026 | 161 | 0.210 |
Why?
| | Spectrum Analysis | 1 | 2004 | 93 | 0.210 |
Why?
| | Spectrometry, Fluorescence | 1 | 2004 | 168 | 0.210 |
Why?
| | NADP | 2 | 2017 | 55 | 0.200 |
Why?
| | Neural Crest | 1 | 2024 | 126 | 0.200 |
Why?
| | Mesoderm | 1 | 2024 | 150 | 0.200 |
Why?
| | Immune Tolerance | 1 | 2026 | 379 | 0.200 |
Why?
| | Tamoxifen | 2 | 2022 | 217 | 0.200 |
Why?
| | Caspase 3 | 1 | 2024 | 238 | 0.200 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2026 | 389 | 0.190 |
Why?
| | In Vitro Techniques | 2 | 2017 | 1047 | 0.190 |
Why?
| | Zebrafish Proteins | 1 | 2026 | 311 | 0.190 |
Why?
| | Disease Models, Animal | 2 | 2026 | 4557 | 0.190 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2023 | 158 | 0.190 |
Why?
| | Cholesterol | 1 | 2004 | 406 | 0.190 |
Why?
| | Superoxide Dismutase | 2 | 2014 | 301 | 0.190 |
Why?
| | Cells, Cultured | 5 | 2014 | 4154 | 0.190 |
Why?
| | Verapamil | 1 | 2022 | 37 | 0.180 |
Why?
| | Peptide Fragments | 1 | 2026 | 699 | 0.180 |
Why?
| | Choline O-Acetyltransferase | 1 | 2021 | 25 | 0.170 |
Why?
| | Hypoglycemia | 1 | 2026 | 477 | 0.170 |
Why?
| | Optical Imaging | 1 | 2021 | 64 | 0.170 |
Why?
| | Cholinergic Fibers | 1 | 2021 | 19 | 0.170 |
Why?
| | Channelrhodopsins | 1 | 2021 | 20 | 0.170 |
Why?
| | Cholinergic Neurons | 1 | 2021 | 18 | 0.170 |
Why?
| | Vagus Nerve Stimulation | 1 | 2021 | 29 | 0.160 |
Why?
| | Biomimetics | 1 | 2021 | 40 | 0.160 |
Why?
| | Perfusion | 1 | 2022 | 250 | 0.160 |
Why?
| | Equipment Design | 3 | 2015 | 530 | 0.160 |
Why?
| | Adenosine Triphosphatases | 1 | 2021 | 162 | 0.160 |
Why?
| | Boron Compounds | 2 | 2015 | 29 | 0.160 |
Why?
| | Embryonic Stem Cells | 1 | 2021 | 130 | 0.160 |
Why?
| | Early Diagnosis | 1 | 2021 | 249 | 0.160 |
Why?
| | Receptors, Immunologic | 1 | 2021 | 206 | 0.160 |
Why?
| | Radiotherapy, Image-Guided | 1 | 2020 | 39 | 0.160 |
Why?
| | Electrophysiological Phenomena | 1 | 2020 | 60 | 0.160 |
Why?
| | DNA | 1 | 2007 | 1463 | 0.150 |
Why?
| | Electrophysiology | 1 | 2020 | 218 | 0.150 |
Why?
| | Animals, Newborn | 2 | 2014 | 902 | 0.150 |
Why?
| | Axons | 1 | 2021 | 201 | 0.150 |
Why?
| | Recombinant Proteins | 2 | 2015 | 1370 | 0.140 |
Why?
| | Diet, High-Fat | 1 | 2020 | 261 | 0.140 |
Why?
| | Phospholipids | 1 | 2020 | 213 | 0.140 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 276 | 0.140 |
Why?
| | Transcription Factors | 1 | 2026 | 1741 | 0.140 |
Why?
| | Potassium Channels, Inwardly Rectifying | 2 | 2024 | 44 | 0.130 |
Why?
| | Cations, Divalent | 1 | 2017 | 47 | 0.130 |
Why?
| | Paracrine Communication | 1 | 2018 | 67 | 0.130 |
Why?
| | Male | 9 | 2026 | 72315 | 0.130 |
Why?
| | Nerve Tissue Proteins | 1 | 2021 | 592 | 0.130 |
Why?
| | Cell Line, Tumor | 3 | 2014 | 3540 | 0.130 |
Why?
| | Biological Clocks | 1 | 2017 | 49 | 0.130 |
Why?
| | Female | 8 | 2026 | 78271 | 0.130 |
Why?
| | Transcriptome | 2 | 2021 | 1045 | 0.130 |
Why?
| | Glucose Tolerance Test | 3 | 2014 | 361 | 0.120 |
Why?
| | Tissue Banks | 1 | 2015 | 17 | 0.120 |
Why?
| | Immunohistochemistry | 2 | 2017 | 1716 | 0.120 |
Why?
| | Apoptosis | 1 | 2024 | 2430 | 0.120 |
Why?
| | Tissue Culture Techniques | 1 | 2015 | 83 | 0.120 |
Why?
| | Transcription, Genetic | 1 | 2021 | 1496 | 0.110 |
Why?
| | Evolution, Molecular | 1 | 2019 | 514 | 0.110 |
Why?
| | Heterocyclic Compounds, 3-Ring | 1 | 2015 | 44 | 0.110 |
Why?
| | Single-Cell Analysis | 1 | 2018 | 358 | 0.110 |
Why?
| | Oxygen | 1 | 2020 | 995 | 0.110 |
Why?
| | Calibration | 1 | 2015 | 151 | 0.110 |
Why?
| | Maf Transcription Factors, Large | 1 | 2014 | 6 | 0.100 |
Why?
| | Enzyme Activation | 1 | 2015 | 766 | 0.100 |
Why?
| | Autoantibodies | 1 | 2021 | 1501 | 0.100 |
Why?
| | Interleukin-1beta | 1 | 2015 | 395 | 0.100 |
Why?
| | Exocytosis | 1 | 2014 | 84 | 0.100 |
Why?
| | Time Factors | 5 | 2014 | 7173 | 0.100 |
Why?
| | Immunotherapy | 1 | 2018 | 653 | 0.100 |
Why?
| | Diagnostic Imaging | 2 | 2007 | 338 | 0.100 |
Why?
| | Computer Simulation | 1 | 2017 | 1025 | 0.090 |
Why?
| | Hypertension, Pulmonary | 2 | 2014 | 1980 | 0.090 |
Why?
| | Cell Survival | 1 | 2015 | 1098 | 0.090 |
Why?
| | Interferon-gamma | 1 | 2015 | 784 | 0.090 |
Why?
| | Enzyme Inhibitors | 1 | 2015 | 824 | 0.090 |
Why?
| | Insulin Resistance | 1 | 2020 | 1241 | 0.090 |
Why?
| | Cyclic AMP | 1 | 2011 | 209 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2015 | 1217 | 0.080 |
Why?
| | GTP-Binding Protein alpha Subunits | 1 | 2010 | 15 | 0.080 |
Why?
| | Models, Theoretical | 1 | 2014 | 582 | 0.080 |
Why?
| | Disease Progression | 1 | 2018 | 2847 | 0.080 |
Why?
| | Cytoplasmic Vesicles | 1 | 2009 | 14 | 0.070 |
Why?
| | Dimethylpolysiloxanes | 1 | 2009 | 9 | 0.070 |
Why?
| | Glycosylphosphatidylinositols | 1 | 2009 | 12 | 0.070 |
Why?
| | Transplantation, Heterotopic | 1 | 2008 | 16 | 0.070 |
Why?
| | Receptors, KIR2DL1 | 1 | 2009 | 21 | 0.070 |
Why?
| | Sequence Deletion | 1 | 2009 | 193 | 0.070 |
Why?
| | HLA-C Antigens | 1 | 2009 | 36 | 0.070 |
Why?
| | Cell Line, Transformed | 1 | 2009 | 140 | 0.070 |
Why?
| | Pancreas Transplantation | 1 | 2008 | 69 | 0.070 |
Why?
| | Electricity | 1 | 2008 | 27 | 0.070 |
Why?
| | Scattering, Radiation | 1 | 2008 | 103 | 0.070 |
Why?
| | NAD | 1 | 2008 | 81 | 0.070 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2009 | 81 | 0.070 |
Why?
| | Mutation | 1 | 2019 | 4089 | 0.070 |
Why?
| | Gene Knockout Techniques | 1 | 2008 | 116 | 0.070 |
Why?
| | Cell Physiological Phenomena | 1 | 2008 | 19 | 0.070 |
Why?
| | Embryo, Mammalian | 2 | 2024 | 232 | 0.070 |
Why?
| | Protein Interaction Mapping | 1 | 2008 | 104 | 0.070 |
Why?
| | Cell Membrane Structures | 1 | 2006 | 5 | 0.060 |
Why?
| | Proteins | 1 | 2013 | 1021 | 0.060 |
Why?
| | Hypoxia | 1 | 2014 | 1199 | 0.060 |
Why?
| | Protein Engineering | 1 | 2008 | 122 | 0.060 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2014 | 2145 | 0.060 |
Why?
| | Signal Transduction | 4 | 2026 | 5226 | 0.060 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2008 | 178 | 0.060 |
Why?
| | Biomarkers | 1 | 2018 | 4271 | 0.060 |
Why?
| | Microchip Analytical Procedures | 1 | 2006 | 5 | 0.060 |
Why?
| | Energy Transfer | 1 | 2006 | 49 | 0.060 |
Why?
| | Cattle | 1 | 2008 | 1000 | 0.060 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2026 | 88 | 0.060 |
Why?
| | Postprandial Period | 1 | 2026 | 118 | 0.060 |
Why?
| | Lab-On-A-Chip Devices | 1 | 2006 | 60 | 0.060 |
Why?
| | Microelectrodes | 1 | 2025 | 47 | 0.060 |
Why?
| | Phagocytosis | 1 | 2006 | 299 | 0.050 |
Why?
| | Microscopy, Video | 1 | 2004 | 25 | 0.050 |
Why?
| | Anisotropy | 1 | 2004 | 75 | 0.050 |
Why?
| | bcl-2-Associated X Protein | 1 | 2024 | 54 | 0.050 |
Why?
| | Diffusion | 1 | 2004 | 121 | 0.050 |
Why?
| | Nanotubes | 1 | 2004 | 48 | 0.050 |
Why?
| | Cytological Techniques | 1 | 2004 | 28 | 0.050 |
Why?
| | Burkitt Lymphoma | 1 | 2004 | 62 | 0.050 |
Why?
| | Cleft Palate | 1 | 2024 | 89 | 0.050 |
Why?
| | Models, Chemical | 1 | 2004 | 269 | 0.050 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2025 | 226 | 0.050 |
Why?
| | Polymerase Chain Reaction | 1 | 2006 | 1054 | 0.050 |
Why?
| | Temperature | 1 | 2006 | 679 | 0.050 |
Why?
| | Haploinsufficiency | 1 | 2022 | 55 | 0.050 |
Why?
| | Bariatric Surgery | 1 | 2026 | 242 | 0.050 |
Why?
| | Respiration | 1 | 2022 | 206 | 0.040 |
Why?
| | Action Potentials | 1 | 2025 | 506 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2006 | 1985 | 0.040 |
Why?
| | Lipid Metabolism | 1 | 2004 | 527 | 0.040 |
Why?
| | Surface-Active Agents | 1 | 2021 | 92 | 0.040 |
Why?
| | Models, Statistical | 1 | 2004 | 681 | 0.040 |
Why?
| | DNA, Mitochondrial | 1 | 2021 | 211 | 0.040 |
Why?
| | Bacteria | 1 | 2006 | 889 | 0.040 |
Why?
| | Lipids | 1 | 2004 | 710 | 0.040 |
Why?
| | Lung | 3 | 2021 | 4109 | 0.040 |
Why?
| | Computational Biology | 1 | 2024 | 680 | 0.040 |
Why?
| | Cell Line | 1 | 2004 | 2882 | 0.040 |
Why?
| | Macrophages | 1 | 2006 | 1511 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 2 | 2019 | 2363 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2006 | 3409 | 0.030 |
Why?
| | Gene Expression Regulation | 2 | 2021 | 2608 | 0.030 |
Why?
| | GTP Cyclohydrolase | 1 | 2014 | 10 | 0.030 |
Why?
| | Soluble Guanylyl Cyclase | 1 | 2014 | 16 | 0.030 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2014 | 23 | 0.030 |
Why?
| | Guanylate Cyclase | 1 | 2014 | 39 | 0.030 |
Why?
| | Estrogen Antagonists | 1 | 2014 | 48 | 0.030 |
Why?
| | Cyclic GMP | 1 | 2014 | 92 | 0.030 |
Why?
| | Sepharose | 1 | 2014 | 32 | 0.030 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2014 | 150 | 0.030 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2014 | 204 | 0.030 |
Why?
| | Adult | 1 | 2017 | 40449 | 0.030 |
Why?
| | Glycine | 1 | 2014 | 187 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 341 | 0.020 |
Why?
| | Arginine | 1 | 2014 | 262 | 0.020 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 209 | 0.020 |
Why?
| | Heparin | 1 | 2014 | 244 | 0.020 |
Why?
| | Neoplasms | 1 | 2008 | 2875 | 0.020 |
Why?
| | Kidney | 1 | 2020 | 1495 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2014 | 636 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2014 | 824 | 0.020 |
Why?
| | Antioxidants | 1 | 2014 | 549 | 0.020 |
Why?
| | Genotype | 1 | 2014 | 1833 | 0.020 |
Why?
| | Printing | 1 | 2009 | 5 | 0.020 |
Why?
| | Streptozocin | 1 | 2008 | 21 | 0.020 |
Why?
| | Brain | 1 | 2021 | 2933 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2014 | 905 | 0.020 |
Why?
| | Pulmonary Artery | 1 | 2014 | 1134 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 983 | 0.020 |
Why?
| | Trans-Activators | 1 | 2010 | 405 | 0.020 |
Why?
| | Blood Pressure | 1 | 2014 | 1769 | 0.020 |
Why?
| | Convallaria | 1 | 2007 | 1 | 0.020 |
Why?
| | Mice, Nude | 1 | 2008 | 682 | 0.020 |
Why?
| | Transport Vesicles | 1 | 2006 | 21 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2009 | 375 | 0.010 |
Why?
| | Cost-Benefit Analysis | 1 | 2009 | 634 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2014 | 2832 | 0.010 |
Why?
| | Biological Transport | 1 | 2006 | 417 | 0.010 |
Why?
| | Arteries | 1 | 2007 | 259 | 0.010 |
Why?
| | Actins | 1 | 2006 | 425 | 0.010 |
Why?
| | Microtubules | 1 | 2006 | 286 | 0.010 |
Why?
| | Skin | 1 | 2008 | 755 | 0.010 |
Why?
| | Cell Movement | 1 | 2006 | 965 | 0.010 |
Why?
| | Endoscopy | 1 | 2004 | 316 | 0.010 |
Why?
| | Risk Factors | 1 | 2014 | 10779 | 0.010 |
Why?
| | Pregnancy | 1 | 2008 | 7190 | 0.010 |
Why?
|
|
Benninger's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|